Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sucampo Pharmaceuticals
Pharma
Jury awards $885M in Takeda pay-for-delay antitrust case
Takeda plans to appeal after a jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million.
Kevin Dunleavy
May 19, 2026 8:39am
Takeda, Endo hit with antitrust suit over pay-for-delay deal
Jun 30, 2021 11:42am
Mallinckrodt moves beyond Acthar with $1.2B Sucampo buy
Dec 27, 2017 6:53pm
Express Scripts formulary knocks Lilly, Amgen meds—plus 62 more
Jul 31, 2017 12:12pm
